Acutus Medical, Inc.’s initial public offering (IPO) will give the company up to $166m to help take on its much larger competitors in the electrophysiology sector, such as Johnson & Johnson/Biosense Webster and Abbott .
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?